Cialis’s primary patents have expired. This means generic versions of tadalafil, the active ingredient in Cialis, are available.
However, Lilly holds patents on specific formulations and uses of tadalafil, which may still offer some level of exclusivity. These patents expire at different times. Consequently, the market availability of various Cialis formulations might differ.
To understand the precise status of any particular Cialis patent, you should consult the United States Patent and Trademark Office (USPTO) database directly. Searching by Lilly’s name and “tadalafil” will yield the most up-to-date information.
| Original Composition of Matter | Expired | Generic tadalafil now widely available |
| Specific Formulations | Vary; Check USPTO | Some Cialis formulations may still be patent-protected |
| Specific Uses (e. g., for BPH) | Vary; Check USPTO | Generic options might not cover all Cialis uses |
Checking the USPTO database provides the most accurate and current details regarding Cialis patent protection in the US.
